305 related articles for article (PubMed ID: 32674116)
21. PROLACTIN LEVELS DO NOT RISE AMONG TRANSGENDER WOMEN TREATED WITH ESTRADIOL AND SPIRONOLACTONE.
Bisson JR; Chan KJ; Safer JD
Endocr Pract; 2018 Jul; 24(7):646-651. PubMed ID: 29708436
[TBL] [Abstract][Full Text] [Related]
22. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
[TBL] [Abstract][Full Text] [Related]
23. Position statement on the hormonal management of adult transgender and gender diverse individuals.
Cheung AS; Wynne K; Erasmus J; Murray S; Zajac JD
Med J Aust; 2019 Aug; 211(3):127-133. PubMed ID: 31271465
[TBL] [Abstract][Full Text] [Related]
24. The effect of testosterone on ovulatory function in transmasculine individuals.
Taub RL; Ellis SA; Neal-Perry G; Magaret AS; Prager SW; Micks EA
Am J Obstet Gynecol; 2020 Aug; 223(2):229.e1-229.e8. PubMed ID: 32044312
[TBL] [Abstract][Full Text] [Related]
25. Ovarian stimulation outcomes among transgender men compared with fertile cisgender women.
Amir H; Yaish I; Samara N; Hasson J; Groutz A; Azem F
J Assist Reprod Genet; 2020 Oct; 37(10):2463-2472. PubMed ID: 32719977
[TBL] [Abstract][Full Text] [Related]
26. Common Hormone Therapies Used to Care for Transgender Patients Influence Laboratory Results.
Humble RM; Imborek KL; Nisly N; Greene DN; Krasowski MD
J Appl Lab Med; 2019 Mar; 3(5):799-814. PubMed ID: 31639755
[TBL] [Abstract][Full Text] [Related]
27. Cross-sex hormone therapy in Australia: the prescription patterns of clinicians experienced in adult transgender healthcare.
Bretherton I; Thrower E; Grossmann M; Zajac JD; Cheung AS
Intern Med J; 2019 Feb; 49(2):182-188. PubMed ID: 29992681
[TBL] [Abstract][Full Text] [Related]
28. Differential Endocrine and Metabolic Effects of Testosterone Suppressive Agents in Transgender Women.
Sofer Y; Yaish I; Yaron M; Bach MY; Stern N; Greenman Y
Endocr Pract; 2020 Aug; 26(8):883-890. PubMed ID: 33471679
[TBL] [Abstract][Full Text] [Related]
29. Prospective Evaluation of Self-Reported Aggression in Transgender Persons.
Defreyne J; T'Sjoen G; Bouman WP; Brewin N; Arcelus J
J Sex Med; 2018 May; 15(5):768-776. PubMed ID: 29699761
[TBL] [Abstract][Full Text] [Related]
30. Sex Differences in Reproductive Hormones During Mini-Puberty in Infants With Normal and Disordered Sex Development.
Johannsen TH; Main KM; Ljubicic ML; Jensen TK; Andersen HR; Andersen MS; Petersen JH; Andersson AM; Juul A
J Clin Endocrinol Metab; 2018 Aug; 103(8):3028-3037. PubMed ID: 29917083
[TBL] [Abstract][Full Text] [Related]
31. Assessment of Gender-Affirming Hormone Therapy Requirements.
Fernandez JD; Kendjorsky K; Narla A; Villasante-Tezanos AG; Tannock LR
LGBT Health; 2019 Apr; 6(3):101-106. PubMed ID: 30810452
[TBL] [Abstract][Full Text] [Related]
32. New Insights Into Extended Steroid Hormone Profiles in Transwomen in a Multi-Center Setting in Germany.
Schneider F; Wistuba J; Holterhus PM; Kulle A; Schlatt S; Kliesch S; Neuhaus N; Zitzmann M
J Sex Med; 2021 Oct; 18(10):1807-1817. PubMed ID: 34600646
[TBL] [Abstract][Full Text] [Related]
33. Is there a need for liver enzyme monitoring in people using gender-affirming hormone therapy?
Stangl TA; Wiepjes CM; Defreyne J; Conemans E; D Fisher A; Schreiner T; T'Sjoen G; den Heijer M
Eur J Endocrinol; 2021 Apr; 184(4):513-520. PubMed ID: 33524005
[TBL] [Abstract][Full Text] [Related]
34. Complex biological pattern of fertility hormones in children and adolescents: a study of healthy children from the CALIPER cohort and establishment of pediatric reference intervals.
Konforte D; Shea JL; Kyriakopoulou L; Colantonio D; Cohen AH; Shaw J; Bailey D; Chan MK; Armbruster D; Adeli K
Clin Chem; 2013 Aug; 59(8):1215-27. PubMed ID: 23637248
[TBL] [Abstract][Full Text] [Related]
35. Reference ranges for serum concentrations of lutropin (LH), follitropin (FSH), estradiol (E2), prolactin, progesterone, sex hormone-binding globulin (SHBG), dehydroepiandrosterone sulfate (DHEAS), cortisol and ferritin in neonates, children and young adults.
Elmlinger MW; Kühnel W; Ranke MB
Clin Chem Lab Med; 2002 Nov; 40(11):1151-60. PubMed ID: 12521235
[TBL] [Abstract][Full Text] [Related]
36. Clinically Relevant Laboratory Monitoring of Gender-Affirming Hormone Therapy in Transgender People-Experiences from a Teaching Hospital in the Netherlands.
Pouw N; van der Linden J; Teuben S; Kos S
J Appl Lab Med; 2024 May; 9(3):440-455. PubMed ID: 38452266
[TBL] [Abstract][Full Text] [Related]
37. Changes in hormonal and metabolic parameters in transgender subjects on cross-sex hormone therapy: A cohort study.
Vita R; Settineri S; Liotta M; Benvenga S; Trimarchi F
Maturitas; 2018 Jan; 107():92-96. PubMed ID: 29169588
[TBL] [Abstract][Full Text] [Related]
38. Effects of cross-sex hormone treatment on transgender women and men.
Deutsch MB; Bhakri V; Kubicek K
Obstet Gynecol; 2015 Mar; 125(3):605-610. PubMed ID: 25730222
[TBL] [Abstract][Full Text] [Related]
39. Urine and Serum Sex Steroid Profile in Testosterone-Treated Transgender and Hypogonadal and Healthy Control Men.
Savkovic S; Lim S; Jayadev V; Conway A; Turner L; Curtis D; Goebel C; Handelsman DJ
J Clin Endocrinol Metab; 2018 Jun; 103(6):2277-2283. PubMed ID: 29584875
[TBL] [Abstract][Full Text] [Related]
40. Advancements in the gold standard: Measuring steroid sex hormones by mass spectrometry.
Conklin SE; Knezevic CE
Clin Biochem; 2020 Aug; 82():21-32. PubMed ID: 32209333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
